IP Library Patent Application 16130498
Patent Application
App. No. 16/130,498

METHOD OF OSTEOGENIC DIFFERENTIATION IN MICROFLUIDIC TISSUE CULTURE SYSTEMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/130,498
Abstract

Microfluidic “organ-on-a-chip” devices have been developed with the aim to replicate human tissues in vitro. However, there is no option to quantitatively monitor biological processes that take place within the chip, over time. Destructive methods in order to analyze, tissue formation, gene expression, protein secretion etc. require the harvest of the “tissue” at a certain time point. Described herein are methods and compositions for non-destructive molecular imaging methods and systems in order to quantitatively monitor specific biological processes, over time, within the chip, without the need to harvest.

Claims (20)

1 - 23 . (canceled)

24 . A method of culturing mesenchymal stem cells (MSCs) comprising flowing culture media over said MSCs in a microfluidic device to produce a higher number of proliferated MSCs in culture than in the absence of said flowing.

25 . The method of claim 24 , wherein the microfluidic device comprises one or more channels.

26 . The method of claim 24 , wherein the flow rate of said culture media is 30 ul per hour.

27 . The method of claim 24 , wherein the microfluidic device comprises a membrane and said cells are attached to said membrane.

28 . The method of claim 24 , wherein proliferation of the cells is monitored without disrupting the culture.

29 . The method of claim 24 , wherein the cells are cultured for three weeks.

30 . The method of claim 24 , further comprising,

adding one or more labeling agents to the microfluidic device; and

detecting the labeling agent.

31 . The method of claim 24 , further comprising,

detecting one or more macromolecules secreted by the MSCs.

32 . A method of osteogenic differentiation comprising flowing osteogenic media over mesenchymal stem cells (MSCs) in an organ-on-a-chip device to produce a higher number of differentiated MSCs in culture that express osteocalcin and bone sialoprotein (bsp) osteogenic markers than in the absence of said flowing.

33 . The method of claim 32 , wherein the microfluidic device comprises one or more channels.

34 . The method of claim 32 , wherein the flow rate of said culture media is 30 ul per hour.

35 . The method of claim 32 , wherein the microfluidic device comprises a membrane and said cells are attached to said membrane.

36 . The method of claim 32 , wherein the cells are cultured for three weeks.

37 . The method of claim 32 , further comprising,

adding one or more labeling agents to the microfluidic device; and

detecting the labeling agent.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2020
From: GAZIT, DAN; PELLED, GADI; GAZIT, ZULMA; SHEYN, DMITRIY; HINOJOSA, CHRISTOPHER DAVID; WEN, NORMAN; HAMILTON, GERALDINE
To: EMULATE, INC.; CEDARS-SINAI MEDICAL CENTER
Reel/Frame 053967/0788 →